Hydroxyurea Capsule
Product Images NDC 67184-0607

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyurea (NDC 67184-0607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (01)

Chemical Structure (01)
Chemical structure of hydroxyurea, showing its molecular arrangement with an amine group, carbonyl group, and hydroxylamine moiety.*
FDA Label Image

Container Label (02)

Container Label (02)
Label for Hydroxyurea Capsules, USP 500 mg by Qilu Pharmaceutical Co., Ltd. The oral capsules come in a bottle containing 100 capsules. The label includes cautionary text about the cytotoxic nature of the agent and instructions regarding storage and handling. The NDC is 67184-0607.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.